CITIC Capital is one of seven cornerstone investors that will cover 43% of Harbin Bank’s Hong Kong IPO, which is expected to raise up to HK$10.1 billion ($1.3 billion), although subscriptions to the offering have reportedly been delayed due to concerns...
Monument Group, a Boston-headquartered placement agent with a presence in the US and UK, has expanded into Asia, with a Hong Kong office now in operation. A Tokyo base will follow later this year.
Sunshine 100 China Holding, a Chinese property developer backed by Warburg Pincus, has launched its Hong Kong IPO, seeking up to HK$2.4 million ($310 million).
Sunfonda Group Holdings, the second largest luxury auto dealer in China - and a Standard Chartered Private Equity (SCPE) portfolio company - plans to raise up to HK$683 million ($88 million) through a Hong Kong IPO.
Hong Kong’s financial secretary, John Tsang, reaffirmed the government’s plans to extend the profits tax exemption for offshore funds to include private equity, promising to “take forward the legislative work as soon as possible.”
China’s National Council for Social Security Fund (NSSF) will commit about $19.8 million as a cornerstone investor in Poly Culture’s HK$2.57 billion ($331 million) Hong Kong IPO.
Chinese display advertising business Focus Media, which was taken private in last May by a consortium of private equity investors in conjunction with company management, is said to be working towards a $1 billion IPO in early 2015.
Fund administrators are seeing increased demand from GPs for back office services in Singapore. Hong Kong isn’t the definitive loser, but the territory’s lack of tax and regulatory certainty for PE is a factor
Accelerated Venture Partners (AVP), a Silicon Valley-based private equity firm, has opened an office in Hong Kong to provide Asian companies with financing and help them go public in the US.
Two private equity-backed Chinese companies – Rundong Automobile Group and Luye Pharma Group – are reportedly planning to raise a total of $1.5 billion through Hong Kong listings.
Navis Capital Partners has acquired a controlling interest in Amazon Papyrus Chemicals Group, a Hong Kong-based chemicals manufacturer that supplies the paper and pulp industry.
Yunfeng Capital and Alibaba Group together plan to buy a 54.3% stake in pharmaceutical data provider CITIC 21CN, a Hong Kong-listed subsidiary of Chinese conglomerate CITIC Group, for HK$1.33 billion ($171 million).
Hamilton Lane has added two senior professionals to its Asia team, appointing Mingchen Xia as principal on the fund investment team and Yen Li Chew as vice president within its business development group - both will be based in Hong Kong.
AAB Group, a Chinese diaper maker backed by RRJ Capital, is said to be looking to raise as much as $300 million through an IPO on the Hong Kong Stock Exchange.
GIC Private has exited its 8.84% stake in Beijing Capital International Airport (BCIA)to NWS Holdings, an Chinese infrastructure conglomerate controlled by Hong Kong billionaire Cheng Yu-Tung, for about HK$2.36 billion ($304 million).
Artgo Mining Holdings, a Chinese marble producer and distributor which is backed by The Carlyle Group, intends to raise up to HK$1.01 billion ($130 million) through an IPO in Hong Kong.
Consun Pharmaceutical Group, a Chinese medicine retailer backed by Hony Capital, is seeking to raise up to HK$1.09 billion ($140 million) through an IPO in Hong Kong.
Asia-focused Hillhouse Capital will commit about HK$274 million ($35 million) as a cornerstone investor in China Conch Venture’s HK$3.59 billion Hong Kong IPO.
“When AIFMD came out in draft form a couple of years ago we engaged the Hong Kong government to participate in the process of seeking comment,” David Pierce, a partner at FLAG Squadron Asia and until recently non-executive chairman of the Hong Kong...
The Carlyle Group and Farallon Capital Management will commit $35 million as cornerstone investors in Fu Shou Yuan International’s $215 million Hong Kong IPO.
Hong Kong-based Horizon Ventures has led a $15.2 million Series B round for Misfit Wearables, the US start-up behind the physical activity monitor Shine. Existing investors – which include Founders Fund, Khosla Ventures, Norwest Venture Partners, OATV,...
In 2010 Japan Home Centre was already a successful domestic brand but to realize its IPO ambitions it needed the right partner to guide it through a period of rapid expansion – EQT Partners
Jintian Pharmaceutical Group, a Chinese pharmaceutical retailer and distributor backed by CVC Capital Partners and SEAVI Advent Private Equity, is seeking to raise as much as $273 million through an IPO in Hong Kong.
PE-backed China Cinda Asset Management Corp, one of four groups set up to absorb non-performing loans (NPLs) from the country’s Big Four state-owned banks, is expected to raise up to $2.5 billion in its Hong Kong IPO.